| Literature DB >> 19530220 |
Dan Zhu1, Lei Wu, Chun-Rong Li, Xiao-Wei Wang, Yong-Jie Ma, Zhi-Yin Zhong, Hai-Bao Zhao, Jian Cui, Si-Fan Xun, Xiu-Lan Huang, Zhe Zhou, Sheng-Qi Wang.
Abstract
Ginsenoside Rg1 is a major active ingredient of Panax notoginseng radix which has demonstrated a number of pharmacological actions including a cardioprotective effect in vivo. This study investigated the protective effect and mechanism of ginsenoside Rg1 in cardiomyocytes hypoxia/reoxygenation (H/R) model. Pretreatment with ginsenoside Rg1 (60-120 microM) reduced lactate dehydrogenase release and increased cell viability in a dose-dependent manner. Fluorescence analysis demonstrated ginsenoside Rg1 reduced intracellular ROS and suppressed the intracellular [Ca(2+)] level. Cell lysate detected an increase of T-SOD, CAT, and GSH levels. The myocardial protection of ginsenoside Rg1 during H/R is partially due to its antioxidative effect and intracellular calcium homeostasis. (c) 2009 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19530220 DOI: 10.1002/jcb.22233
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429